AbbVie Earnings Beat Estimates as Botox Shows Signs of Revival
Earnings·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
AbbVie Inc. reported second quarter profit and sales that topped Wall Street’s expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.
The company's performance indicates a positive trend in its product lines, particularly with Botox, which has shown signs of revival in the market.
AbbVie
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“AbbVie Inc. reported second quarter profit and sales that topped Wall Street’s expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.”
Bloomberg — AbbVie Earnings Beat Estimates as Botox Shows Signs of Revival